Cardiovascular Medicine Book



Aka: Methyl-Dopa, Methyldopa, Alpha Methyldopa, Aldomet
  1. See Also
    1. Alpha Adrenergic Central Agonist
    2. Clonidine
    3. Guanabenz (Wytensin)
    4. Guanfacine (Tenex)
  2. Indications
    1. Hypertension in Pregnancy
  3. Safety
    1. Long safety record in pregnancy
  4. Disadvantages
    1. Weak antihypertensive
    2. Less tolerated (Fatigue, Dizziness) than other agents
  5. Contraindications
    1. Significant Liver Disease
  6. Pharmacokinetics
    1. Renal excretion (metabolized or 63% as unchanged in urine)
  7. Dosing: Hypertension in Pregnancy
    1. Start: 250 mg orally twice to three times daily
    2. Maintenance: 500 mg orally twice daily
    3. Maximum: Up to 3000 mg daily in divided doses
  8. Dosing: Hypertensive Crisis
    1. Start: 250-500 mg IV every 6 hours (up to 1000 mg every 6 hours)
  9. Dosing: Pediatric Hypertension
    1. Dose: 10 mg/kg/day divided bid to qid
    2. Maximum: 65 mg/kg/day up to 3000 mg/day in divided doses
  10. Mechanism
    1. See Alpha Adrenergic Central Agonist
    2. See Alpha Adrenergic Receptor
    3. Central Acting Adrenergic Agonist
      1. Activates alpha-2 receptors that inhibit CNS sympathetic signals (similar to Clonidine)
      2. Results in increased parasympathetic effects and side effects
    4. Methylnorepinephrine (Methyldopa) metabolite
      1. Weak Sympathomimetic that also decreases CNS sympathetic outflow
  11. Adverse Effects
    1. Somnolence
    2. Dry Mouth
    3. Orthostatic Hypotension or Dizziness
    4. Erectile Dysfunction
    5. Nightmares
    6. Involuntary movements
    7. Hepatotoxicity
    8. Sodium and water retention
      1. Reflex renin release in response to excessive Clonidine and renal hypoperfusion
      2. Discontinue for Congestive Heart Failure signs
    9. Hemolytic Anemia (rare, serious)
      1. Monitor Complete Blood Count
  12. Drug Interactions
    1. Tricyclic Antidepressants
      1. Decreased Clonidine antihypertensive effect
    2. CNS Depressants (e.g. Alcohol, Benzodiazepines, Barbiturates)
      1. Increase Clonidine related CNS effects (e.g. Somnolence)
  13. References
    1. Olson (2020) Clinical Pharmacology, MedMaster, Miami, p. 64-5
    2. Hamilton (2010) Tarascon Pocket Pharmacopeia, Jones and Bartlett, p. 76
Medication Costs
Methyldopa (on 6/18/2017 at
Methyldopa 250mg #60 tablets for $4.00 $0.07 each
Methyldopa 250mg #180 tablets for $10.00 $0.06 each
methyldopa (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
METHYLDOPA 250 MG TABLET Generic $0.10 each
METHYLDOPA 500 MG TABLET Generic $0.27 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Methyldopa (C0025741)

Definition (NCI) A phenylalanine derivative and an aromatic amino acid decarboxylase inhibitor with antihypertensive activity. Methyldopa is a prodrug and is metabolized in the central nervous system. The antihypertensive action of methyldopa seems to be attributable to its conversion into alpha-methylnorepinephrine, which is a potent alpha-2 adrenergic agonist that binds to and stimulates potent central inhibitory alpha-2 adrenergic receptors. This results in a decrease in sympathetic outflow and decreased blood pressure.
Definition (MSH) An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
Concepts Pharmacologic Substance (T121) , Neuroreactive Substance or Biogenic Amine (T124) , Amino Acid, Peptide, or Protein (T116)
MSH D008750
SnomedCT 373542000, 84078002
LNC LP16200-5, MTHU016766
English Alphamethyldopa, alpha Methyl L Dopa, alpha Methyldopa, alpha-Methyl-L-Dopa, alpha-Methyldopa, methyldopa, L-Tyrosine, 3-hydroxy-alpha-methyl-, 3-Hydroxy-alpha-methyl-L-tyrosine, L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic Acid, Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine, O methyl DOPA, methyldopa (medication), Methyldopa [Chemical/Ingredient], alphamethyldopa, alpha-methyldopa, alpha methyldopa, METHYLDOPA, Methyldopa, Alpha methyldopa, Methyldopa (product), Methyldopa (substance)
Swedish Metyldopa
Czech methyldopa
Finnish Metyylidopa
Japanese α-メチルドーパ, メチルドパ, メチルドーパ, アルファ-メチルドーパ
Spanish alfa-Metildopa, metildopa (producto), metildopa (sustancia), metildopato, metildopa, Metildopa
French alpha-Méthyldopa, alpha-L-Méthyldopa, Méthyldopa
Polish Metylodopa
German Alphamethyldopa, Methyldopa
Italian Metildopa
Portuguese alfa-Metildopa, Metildopa
Derived from the NIH UMLS (Unified Medical Language System)

Aldomet (C0591055)

Concepts Pharmacologic Substance (T121) , Amino Acid, Peptide, or Protein (T116)
MSH D008750
English aldomet, Aldomet, Biopat Brand of Methyldopa, Cahill May Roberts Brand of Methyldopa, Merck Brand of Methyldopa, Merck Sharp & Dohme Brand of Methyldopa, Methyldopa Biopat Brand, Methyldopa Merck Brand
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree